Volume 0 Issue 3 | April 2012
With lightning-fast speed, LC-MS systems have rapidly evolved into today’s highly functional tools. But where did they begin? “When LC-MS instruments first came out 15 to 20 years ago, the main issue was just getting them to work,”
Like much of the instrumentation used in life science laboratories nowadays, LC-MS instruments have become faster, more accurate, and easier to use over the course of their evolution. These days, there are specific minimum requirements that every
In today’s economic climate, it is necessary to ensure that all purchased equipment will provide a return on investment.
Q: Please tell me how your company uses mass spectrometry A: UCB uses mass spectrometry in several different ways. Our lab in the Department of Physical and Analytical Sciences, New Medicines, uses it for a broad range of applications. At the
OUR USER: Rachel Garlish, Ph.D., Principal Scientist, UCB, Slough, UK
Stephen Barnes, Ph.D., Professor of Pharmacology & Toxicology and Director of the Targeted Metabolomics and Proteomics Laboratory at the University of Alabama at Birmingham (UAB), talks about the changes taking place in the field of mass
Stephen Barnes, Ph.D., Professor of Pharmacology & Toxicology and Director f the Targeted Metabolomics and Proteomics Laboratory at the University of Alabama at Birmingham (UAB), talks about the changes taking place in the field of mass spectrometry (MS) as it migrates from the research lab to a clinical environment, for analysis of small molecules as well as large molecules like proteins and lipids. He also discusses some of the challenges facing MS users, particularly with data analysis and storage, when working with large amounts of MS data.